Fibrin-nonspecific agents in the direct thrombolytic treatment of venous sinus thrombosis

QJM: An International Journal of Medicine

Volumn 95, Issue 11, 2002, Pages 763-764

  Yang, Y H ^a   Liu, C K ^a   Shih, M C ^a   Chou, M S ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; STREPTOKINASE; UROKINASE; WARFARIN;

ANAPHYLAXIS; CEREBRAL SINUS THROMBOSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEVER; FIBRINOLYTIC THERAPY; HUMAN; LETTER; LEUKOCYTOSIS; PATHOGENESIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL;

EID: 0036843021     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/95.11.763     Document Type: Letter

References (6)

1. Kimber J. Cerebral venous sinus thrombosis. Q J Med 2002; 95:137-42.
2. Einhäupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338:597-600.
3. van den Berg JSP, Boerman RH, van der Stolpe A, Kremer HPH. Cerebral venous thrombosis: recurrence with fatal course. J Neurol 1999; 246:144-6.
4. Rael JR, Orrison, Jr WW, Baldwin N, Sell J. Direct thrombolysis of superior sagittal sinus thrombosis with coexisting intracranial hemorrhage. AJNR 1997; 18:1238-42.
5. Niwa J, Ohyama H, Matumura S, Maeda Y, Shimizu T. Treatment of acute superior sagittal sinus thrombosis by t-PA infusion via venography: direct thrombolytic therapy in the acute phase. Surg Neurol 1998; 49:425-9.
6. D'Alise MD, Fichtel F, Horowitz M. Sagittal sinus thrombosis following minor head injury treated with continuous urokinase infusion. Surg Neurol 1998; 49:430-5.